Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05869539
Title ACT-TIL and ANV419 for Advanced Melanoma. (BaseTIL-03M)
Acronym BaseTIL-03M
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital, Basel, Switzerland
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE


No variant requirements are available.